{"id":127402,"date":"2026-10-04T10:30:24","date_gmt":"2026-10-04T05:00:24","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=127402"},"modified":"2026-10-04T11:57:27","modified_gmt":"2026-10-04T06:27:27","slug":"child-leprosy-in-india","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/child-leprosy-in-india\/","title":{"rendered":"Child Leprosy in India: Why the 2027 Elimination Goal Is at Risk"},"content":{"rendered":"<h2><b>Child Leprosy Latest News<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">India recorded <\/span><b>3,832 new <\/b><a href=\"https:\/\/vajiramandravi.com\/current-affairs\/leprosy\/\" target=\"_blank\"><b>leprosy<\/b><\/a><b> cases<\/b><span style=\"font-weight: 400;\"> among children in 2025\u201326, including 37 cases with Grade-2 Disability (G2D) at diagnosis \u2014 a marker of delayed detection. This child caseload is 91.6% higher than the <\/span><a href=\"https:\/\/vajiramandravi.com\/current-affairs\/national-leprosy-eradication-programme\/\" target=\"_blank\"><b>National Leprosy Eradication Programme<\/b><\/a><b>&#8216;s (NLEP)<\/b><span style=\"font-weight: 400;\"> target of 2,000 cases for the year.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">These figures, drawn from the latest NLEP annual report, emerge even as India pursues its <\/span><b>National Strategic Plan for Leprosy 2023\u201327<\/b><span style=\"font-weight: 400;\">, which aims to interrupt transmission at the district level by 2027.<\/span><\/li>\n<\/ul>\n<h2><b>Understanding the Target Framework<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Under the national roadmap:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">A district is considered to have &#8220;interrupted transmission&#8221; after reporting <\/span><b>zero <\/b><span style=\"font-weight: 400;\">new indigenous child cases for <\/span><b>five consecutive years.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">NLEP&#8217;s programme objectives include:\u00a0<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"3\"><span style=\"font-weight: 400;\">Zero disability among new child cases.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"3\"><span style=\"font-weight: 400;\">A national G2D rate of less than one case per million population.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The roadmap had projected just 1,000 child cases and a G2D rate of 0.5 per million for 2026\u201327 \u2014 targets the current data suggest are now far out of reach.<\/span><\/li>\n<\/ul>\n<h2><b>Why Child Cases and Disability Matter: The Epidemiological Logic<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The World Health Organisation (WHO) treats <\/span><b>two specific indicators<\/b><span style=\"font-weight: 400;\"> as critical markers of disease control progress:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">New cases among children below 15 years indicate <\/span><b>recent transmission<\/b><span style=\"font-weight: 400;\"> \u2014 since children typically wouldn&#8217;t have been infected long ago, their diagnosis signals the disease is still actively spreading.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">G2D among newly detected patients indicates <\/span><b>delayed diagnosis<\/b><span style=\"font-weight: 400;\"> \u2014 visible disability only develops after the infection has progressed significantly, meaning the patient wasn&#8217;t caught early.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Together, WHO notes, disabilities among newly detected child cases signal both delayed detection and ongoing transmission simultaneously \u2014 making this one of the <\/span><b>most sensitive indicators<\/b><span style=\"font-weight: 400;\"> for tracking whether a leprosy programme is truly working.<\/span><\/li>\n<\/ul>\n<h2><b>A Troubling Trend Over Time<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">India&#8217;s G2D figures among children, year by year:<\/span><\/li>\n<\/ul>\n<figure id=\"attachment_127430\" aria-describedby=\"caption-attachment-127430\" style=\"width: 402px\" class=\"wp-caption alignnone\"><img decoding=\"async\" class=\"size-full wp-image-127430\" src=\"https:\/\/vajiramias.sgp1.cdn.digitaloceanspaces.com\/wp\/current-affairs\/2026\/10\/04115208\/Leprosy-G2D-Trend.jpg\" alt=\"Leprosy G2D Trend\" width=\"412\" height=\"257\" srcset=\"https:\/\/vajiramias.sgp1.cdn.digitaloceanspaces.com\/wp\/current-affairs\/2026\/10\/04115208\/Leprosy-G2D-Trend.jpg 412w, https:\/\/vajiramias.sgp1.cdn.digitaloceanspaces.com\/wp\/current-affairs\/2026\/10\/04115208\/Leprosy-G2D-Trend-410x257.jpg 410w\" sizes=\"(max-width: 412px) 100vw, 412px\" \/><figcaption id=\"caption-attachment-127430\" class=\"wp-caption-text\">Leprosy G2D Trend<\/figcaption><\/figure>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">While the latest figure (37) is lower than several earlier years, the persistent detection of children with disability \u2014 year after year \u2014 directly contradicts NLEP&#8217;s stated objective of &#8220;<\/span><b><i>zero disability among new child cases<\/i><\/b><span style=\"font-weight: 400;\">.&#8221;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This raises a fundamental question: if India is working to interrupt transmission by 2027, why are children still developing leprosy, and why are some only being diagnosed after visible disability has appeared?<\/span><\/li>\n<\/ul>\n<h2><b>The National Picture<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">According to the Union Health Ministry, India detected 91,783 new leprosy cases overall in 2025\u201326.<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Prevalence rate<\/b><span style=\"font-weight: 400;\">: 0.56 per 10,000 population.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">1,945 patients had Grade-2 Disability at diagnosis \u2014 2.12% of all newly detected cases.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>National G2D rate<\/b><span style=\"font-weight: 400;\">: 1.34 per million \u2014 above the NLEP&#8217;s target of less than one case per million.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><b>India&#8217;s Position Globally<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">According to the WHO&#8217;s latest global update, India reported the world&#8217;s largest number of newly detected leprosy cases in 2025:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">India &#8211; 91,783<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Brazil &#8211; 22,901<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Indonesia &#8211; 16,292<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Together, these three countries accounted for 78.3% of all new cases reported globally.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">India also reported the <\/span><b>world&#8217;s largest number of new child leprosy cases<\/b><span style=\"font-weight: 400;\"> globally \u2014 the same 3,832 cases, with 37 children having G2D, as recorded in WHO&#8217;s table.<\/span><\/li>\n<\/ul>\n<h2><b>Where the Burden Is Concentrated<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The Health Ministry has identified specific high-priority states and districts where leprosy prevalence remains concentrated \u2014 defined as districts with a prevalence rate above one case per 10,000 population:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Chhattisgarh: 23 districts<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Jharkhand: 21 districts<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Maharashtra: 18 districts<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Odisha: 18 districts<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Madhya Pradesh: 10 districts<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">These high-endemic and hard-to-reach areas are being prioritised for intensified case detection.<\/span><\/li>\n<\/ul>\n<h2><b>The Programme&#8217;s Response Strategy<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">NLEP&#8217;s current approach emphasises:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Active case detection<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Household contact surveys<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Focused campaigns in high-burden areas<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Special plans for hard-to-reach areas<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The programme also explicitly identifies stigma and discrimination as continuing concerns that likely contribute to delayed self-reporting and diagnosis.<\/span><\/li>\n<\/ul>\n<h2><b>About the Disease<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Leprosy, also known as Hansen&#8217;s disease, is a chronic bacterial infection caused mainly by Mycobacterium leprae.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It primarily affects the skin and peripheral nerves. Transmission occurs mainly through prolonged, close contact with an untreated person.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Importantly, the disease is curable with multidrug therapy (MDT).<\/span><\/li>\n<\/ul>\n<h2><b>Conclusion<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The numbers tell two stories at once \u2014 overall case detection may be improving, but children are still being infected and some are still reaching diagnosis only after visible disability sets in.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">That combination points squarely at gaps in early detection and persistent transmission, not a disease in retreat.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">With 2027 just a year away, closing this gap in high-burden districts like Chhattisgarh and Jharkhand will determine whether India&#8217;s elimination goal is met or merely postponed.<\/span><\/li>\n<\/ul>\n<p><b>Source:<\/b> <strong><a href=\"https:\/\/www.thehindu.com\/news\/national\/3832-children-diagnosed-with-leprosy-as-india-targets-interruption-of-transmission-by-2027\/article71540064.ece\" target=\"_blank\" rel=\"nofollow noopener\">TH<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Child leprosy in India remains a concern, putting the National Leprosy Eradication Programme\u2019s 2027 goal at risk.<\/p>\n","protected":false},"author":18,"featured_media":127433,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[10654,60,22,59],"class_list":["post-127402","post","type-post","status-publish","format-standard","has-post-thumbnail","category-upsc-mains-current-affairs","tag-child-leprosy","tag-mains-articles","tag-upsc-current-affairs","tag-upsc-mains-current-affairs","no-featured-image-padding"],"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/127402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=127402"}],"version-history":[{"count":4,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/127402\/revisions"}],"predecessor-version":[{"id":127432,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/127402\/revisions\/127432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/127433"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=127402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=127402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=127402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}